Life Sciences

Delinking the cost of R&D from the final prices of medicines and making governments the funders and planners of drug development would be rife with problems.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
December 5, 2012
Further evidence that debunks the myth that pharmaceutical companies aren't providing real value to the economy.
October 2, 2012
Rob Atkinson will present at FTC workshop "Competition & Consumer Protection Issues in the Pet Medications Industry"
September 12, 2012
Non-partisan report evaluates the candidates' positions on innovation-based policy.
September 5, 2012
As the 2012 presidential campaign moves in the final stage, ITIF is presenting general principles and specific recommendations across several policy areas.
August 28, 2012
Negotiations toward the TPP Agreement should conclude with a gold-standard trade agreement.
July 23, 2012
Pharmaceutical proliferation leads to longer, wealthier lives.
July 9, 2012
Based on ITIF’s reports, the unfortunate unemployment in life science and STEM fields has to do with inattention to public policies to keep the U.S. at the cutting edge of innovation.
May 17, 2012
The U.S. needs to re-examine its competitiveness in the life sciences sector.
May 17, 2012
Documents the role public investment plays in underpinning a nation’s competitiveness in the life sciences and competition for global life sciences leadership. NIH Director Francis S. Collins endorses this report in a recent New York Times interview.
November 2, 2011
Join us for an international forum discussing the future of health care innovation in times of financial crisis.

Pages